Immunity for Health: Vaccines & Immunotherapy

16–17 Oct 2024 | RodeBol Events

Lien Van Eyck

Clinical Development Lead

Astrivax

Leuven, Belgium

2 profile visits

Accountable for the design, conduct and analysis of the Phase I-II Clinical Development activities for multiple vaccine programs at Astrivax Therapeutics

About me

Dr Lien Van Eyck is a paediatrician and mechanical engineer. She holds a PhD in Immunology, focusing on the identification of disease-causing genetic variants in patients with severe early-onset immunological disorders. After training as a paediatrician, she transitioned to the pharmaceutical industry, gaining extensive experience in early-phase clinical trials, vaccine development and medical affairs at Pfizer and GSK. During her time at Pfizer, she completed a post-graduate program in pharmaceutical development sciences. She currently serves as Clinical Development Lead at Astrivax Therapeutics in Leuven, Belgium.

My organisation

Astrivax

AstriVax NV is a privately held Belgian company founded in 2022 based on vaccine technology developed at the Rega Institute (KU Leuven). AstriVax is developing a first-in-class Plug & Play vaccine platform, for the development of prophylactic and therapeutic vaccines.

Social media

Skills

  • clinical research
  • Immunology
  • İnfectious disease
  • early-phase clinical trials
  • vaccine development
  • Pediatrics

Additional questions

How would you categorise yourself?

ResearcherHealth care professional

Organisation Type

Biotech company/R&D

Areas of expertise

Data management, analytics and monitoringResearch and developmentVaccine R&DDiagnosticsClinical development and trialsOther

Therapeutic areas

Infectious diseases ImmunologyAutoimmune disorders Rare diseases

1. I accept the General Terms & Conditions and Privacy Statement, available on flandersvaccine.be and agree that pictures can be taken at the event and be used for Flanders Vaccine communication purposes.

I agree